Stocks · Health care · Biological Products, (No Diagnostic Substances)

FENNEC PHARMACEUTICALS INC.

FENC Clue Score47
United States Fiscal year ends December CIK 0001211583 Results filed 24 Mar 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Robert Andrade
28 Aug 2026
Chief Financial Officer
Exercised, kept
21,928
$5.10
$111.83K
Christiana Marie Cioffi
26 Mar 2026
Chief Strategy Officer
Exercised, kept
4,700
$4.23
$19.88K
Robert Andrade
26 Mar 2026
Chief Financial Officer
Exercised, kept
13,072
$5.10
$66.67K
Robert Andrade
18 Feb 2026
Chief Financial Officer
Exercised, kept
2,450
$4.08
$10.00K
Robert Andrade
23 Jan 2026
Chief Financial Officer
Exercised, kept
10,000
$2.45
$24.50K
Robert Andrade
15 Jan 2026
Chief Financial Officer
Exercised, kept
10,000
$2.45
$24.50K
Robert Andrade
7 Jan 2026
Chief Financial Officer
Exercised, kept
14,184
$2.45
$34.75K

What was left out

Form 4 filings counted 79
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 9
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 464,085
History held since 2 May 2007